Welcome to CDC Stacks | Providers of Follow-Up Care in a Population-Based Sample of Breast Cancer Survivors - 41951 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Providers of Follow-Up Care in a Population-Based Sample of Breast Cancer Survivors
Filetype[PDF - 152.67 KB]


Details:
  • Pubmed ID:
    24481682
  • Pubmed Central ID:
    PMC3991008
  • Description:
    Purpose

    To describe which providers provide breast cancer survivorship care.

    Patients and Methods

    We conducted a longitudinal survey of non-metastatic breast cancer patients identified by the SEER registries of Los Angeles and Detroit. Multinomial logistic regression examined the adjusted odds of surgeon compared with a medical oncologist follow up or primary care provider compared with medical oncologist follow up, adjusting for age, race/ethnicity, insurance, tumor stage, receipt of chemotherapy, endocrine therapy use, and visit to a medical oncologist at the time of diagnosis. Results were weighted to account for sample selection and non-response.

    Results

    844 women had invasive disease and received chemotherapy or endocrine therapy. 65.2% reported medical oncologists as their main care provider at four years, followed by PCP/other physicians (24.3%) and surgeons (10.5%). Black women were more likely to receive their follow-up care from surgeons (OR 2.47, 95% CI 1.16–5.27) or PCP/other physicians (OR 2.62, 95% CI 1.47–4.65) than medical oncologists. Latinas were more likely to report PCP/other physician follow up than medical oncologists (OR 2.33, 95% CI 1.15–4.73). Compared with privately-insured women, Medicaid recipients were more likely to report PCP/other physician follow up (OR 2.52, 95% CI 1.24–5.15). Women taking endocrine therapy four years after diagnosis were less likely to report surgeons or PCP/other physicians as their primary provider of breast cancer follow up care.

    Conclusions

    Different survivorship care patterns based on race/ethnicity and insurance status. Interventions are needed to inform patients and providers on the recommended sources of breast cancer follow up.

  • Document Type:
  • Collection(s):
  • Funding:
    R01 CA088370/CA/NCI NIH HHS/United States
    K05 CA111340/CA/NCI NIH HHS/United States
    R00 NR010750/NR/NINR NIH HHS/United States
    R01 CA139014/CA/NCI NIH HHS/United States
    U58 DP000807/DP/NCCDPHP CDC HHS/United States
    N01PC54404/CA/NCI NIH HHS/United States
    N01PC35145/CA/NCI NIH HHS/United States
    N01PC35139/CA/NCI NIH HHS/United States
    R01 CA109696/CA/NCI NIH HHS/United States
No Related Documents.
You May Also Like: